The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Because of the variable clinical course of multiple myeloma, the identification of prognostic parameters is of clinical interest. Therefore, we analyzed the clinical significance of serum levels of soluble human leukocyte antigen class I molecules (sHLA-I), carboxy-terminal telopeptide of type-I col...
Main Authors: | Schütt, P, Rebmann, V, Brandhorst, D, Wiefelspütz, J, Ebeling, P, Opalka, B, Seeber, S, Nowrousian, MR, Moritz, T, Grosse-Wilde, H |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2008
|
相似書籍
-
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
由: Rebmann, V, et al.
出版: (2007) -
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
由: Schütt, P, et al.
出版: (2005) -
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
由: Schütt, P, et al.
出版: (2005) -
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
由: Schütt, P, et al.
出版: (2006) -
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
由: Schütt, P, et al.
出版: (2005)